Health Catalyst (HCAT) Rule 144 Notice — 4,578 Shares via Morgan Stanley

Rhea-AI Filing Summary

Health Catalyst, Inc. Form 144 summary: This notice reports a proposed sale of 4,578 shares of common stock through Morgan Stanley Smith Barney LLC on 09/02/2025 with an aggregate market value of $15,394.44. The filing shows the shares were acquired as restricted stock from Health Catalyst, Inc. on 09/02/2025 as compensation. The filer previously sold 4,747 restricted shares on 06/02/2025 for gross proceeds of $17,254.40. The issuer's outstanding shares are listed as 70,373,625. Some filer identification fields (CIK/CCC and contact details) are not provided in the visible content.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for an insider/affiliate sale of a modest number of shares; appears non-material to company valuation.

This Form 144 documents a proposed disposition of 4,578 common shares via a broker on 09/02/2025, acquired the same day as restricted stock and designated as compensation. The amounts disclosed (aggregate value $15,394.44) are small relative to the issuer's outstanding shares of 70,373,625, indicating limited direct market impact. Prior sale of 4,747 shares for $17,254.40 is disclosed for the prior three months, showing recent liquidity activity by the same account.

Compliance/Risk Analyst

TL;DR: Filing meets Rule 144 disclosure elements; missing some filer-identification fields in the provided excerpt.

The notice includes required transactional details: title, broker, number of shares, market value, acquisition date, nature of acquisition, and payment nature. It also contains the seller representation regarding lack of undisclosed material adverse information. The visible content omits full filer CIK/CCC and contact data, which are typically present in a complete filing; confirm the complete filing to verify signature and contact information were properly submitted.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	4578	15394.44	70373625	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	Restricted Stock	Health Catalyst, Inc.			4578	09/02/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin Freeman c/o 10897 South River From Parkway #300 South Jordan UT 84095	Restricted Stock	06/02/2025	4747	17254.4

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)